中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2017, Vol. 46 ›› Issue (12): 1067-1070.doi: 10.12007/j.issn.0258-4646.2017.12.003

• 论著 • 上一篇    下一篇

双特异性磷酸酶6在卵巢浆液性上皮肿瘤中的表达及临床意义

徐平平, 倪莎, 周欣   

  1. 中国医科大学附属盛京医院妇产科, 沈阳 110004
  • 收稿日期:2017-06-07 出版日期:2017-12-30 发布日期:2017-12-08
  • 通讯作者: 周欣 E-mail:zhouxin001@medmail.com.cn
  • 作者简介:徐平平(1989-),女,医师,硕士.
  • 基金资助:
    辽宁省教育厅重点实验室项目(LS201602);沈阳市科技创新专项资金(F15-139-9-34)

Expression of Dual-specificity Phosphatase 6 in Ovarian Serous Epithelial Carcinomas and Its Clinical Significance

XU Pingping, NI Sha, ZHOU Xin   

  1. Department of Obstetrics and Gynecology, Shenjing Hospital, China Medical University, Shenyang 110004, China
  • Received:2017-06-07 Online:2017-12-30 Published:2017-12-08

摘要: 目的 探讨双特异性磷酸酶6(DUSP6)在卵巢浆液性上皮肿瘤中的表达及临床意义。方法 采用免疫组化方法研究DUSP6在不同卵巢浆液性肿瘤组织标本中的表达情况,分析其与临床病理特征的相关性。结果 DUSP6在卵巢浆液性癌中的表达水平明显低于卵巢良性及交界性浆液性肿瘤(均P < 0.001)。DUSP6在卵巢浆液性癌中的表达CA125 ≤ 900 U/mL组低于CA125>900 U/mL组(P < 0.05);DUSP6在卵巢浆液性癌中的表达腹水≤ 500 mL组低于腹水>500 mL组(P < 0.05)。结论 DUSP6表达与卵巢浆液性癌的发生相关,并且可能参与了卵巢浆液性癌的盆腹腔转移过程,可能成为卵巢浆液性癌早期诊断及阻断盆腹腔转移的新的分子标志物。

关键词: 双特异性磷酸酶6, 卵巢浆液性癌, 腹水, CA125

Abstract: Objective To investigate the expression of dual-specificity phosphatase 6(DUSP6) in ovarian epithelial serous tumors and the relationship between DUSP6 expression and the clinicopathological parameters of ovarian serous cystoadenocarcinoma. Methods The expression of DUSP6 was analyzed by immunohistochemistry. Relationships between the expression of DUSP6 and the clinicopathological parameters of ovarian serous cystadenocarcinoma were also analyzed. Results DUSP6 expression was lower in patients with ovarian serous cystadenocarcinoma group with serum CA125 levels of less than or equal to 900 U/mL than in patients with serum CA125 levels of greater than 900 U/mL (P < 0.05) and in patients whose ascites volume was less than or equal to 500 mL than in patients whose ascites volume was greater than 500 mL (P < 0.05). Conclusion DUSP6 is related to the occurrence of ovarian serous carcinoma and is potentially related to the peritoneal metastasis of ovarian serous carcinoma. DUSP6 may be a new molecule for the early diagnosis and therapy of ovarian serous carcinoma and peritoneal metastasis.

Key words: dual-specificity phosphatase 6, ovarian serous carcinoma, ascite, CA125

中图分类号: 

  • R711.75
[1] ARKELL RS,DICKINSON RJ,SQUIREES M,et al. DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5[J]. Cell Signal,2008,20(5):836-843. DOI:10.1016/j.cellsig.2007.12.014.
[2] FURUKAWA T,SUNAMURA M,MOTOI F,et al. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer[J]. Am J Pathol,2003,162(6):1807-1815. DOI:10.1016/S0002-9440(10) 64315-5.
[3] ZHAI X,HAN Q,SHAN Z,et al. Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells[J]. Mol Med Rep,2014,10(6):3052-3058. DOI:10.3892/mmr.2014.2575.
[4] MA JJ,YU XY,GUO L,et al. DUSP6,a tumor suppressor,is involved in differentiation and apoptosis in esophageal squamous cell carcinoma[J]. Oncol Lett,2013,6(6):1624-1630. DOI:10.3892/ol.2013.1605.
[5] DEGL'INNOCENTI D,ROMEO P,TARANTINO E,et al. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells[J]. Endocr Relat Cancer,2013,20(1):23-27. DOI:10.1530/ERC-12-0078.
[6] LEE JU,HUANG S,LEE MH,et al. Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer[J]. Eur J Endocrinol,2012,167(1):93-101. DOI:10.1530/EJE-12-0010.
[7] YANG B,TAN Y,SUN H,et al. Higher intratumor than peritumor expression of DUSP6/MKP-3 is associated with recurrence after curative resection of hepatocellular carcinoma[J]. Chin Med J (Engl),2014,127(7):1211-1217. DOI:10.3760/cma.j.issn.0366-6999.20122329.
[8] LI W,SONG L,RITCHIE AM,et al. Increased levels of DUSP6 phosphatase stimulate tumourigenesis in a molecularly distinct melanoma subtype[J]. Pigment Cell Melanoma Res,2012,25(2):188-199. DOI:10.1111/j.1755-148X.2011.00949.x.
[9] FURUKAWA T,YATSUOKE T,YOUSSEF EM,et al. Genomic analysis of DUSP6,a dual specificity MAP kinase phosphatase,in pancreatic cancer[J]. Cytogenet Cell Genet,1998,82(3/4):156-159. DOI:10.1159/000015091.
[10] EKEROT M,STAVRIDIS MP,DELAVAINE L,et al. Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter[J]. Biochem J,2008,412(2):287-298. DOI:10.1042/BJ20071512.
[11] CHAN DW,LIU VW,TSAU GS,et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells[J]. Carcinogenesis,2008,29(9):1742-1750.DOI:10.1093/carcin/bgn167.
[1] 王莹,刘维新,邢俊伟,周凤,于艳红,王婷. 肝硬化患者血浆B 型利尿肽水平的变化及其临床意义[J]. 中国医科大学学报, 2016, 45(1): 45-47.
[2] 张萍,王敏,接智慧,双婷,闫效宇,周莹莹,吴建磊. miR?210在化疗耐药与化疗敏感卵巢浆液性癌组织中的检测及意义[J]. 中国医科大学学报, 2014, 43(6): 487-492.
[3] 陈曦,宗志红,陈说,修银铃,孙凯旋,赵杨. 细胞角蛋白7与细胞角蛋白20联合检测在鉴别卵巢及胃肠道来源性肿瘤中的诊断价值[J]. 中国医科大学学报, 2014, 43(6): 530-532.
[4] 杜亚奇,刘东屏,王学梅,孙明军. 超声引导下网膜活检在腹水病因诊断中的临床优越性[J]. 中国医科大学学报, 2013, 42(4): 355-356.
[5] 陶陶,王敏. 化疗耐药及敏感卵巢癌细胞差异表达microRNA的筛查与组织鉴定[J]. 中国医科大学学报, 2013, 42(2): 118-122.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA